Dr. Dustin Deming, M.D.
Claim this profileUniversity of Wisconsin Carbone Cancer Center
Area of expertise
Pancreatic Cancer
Dustin Deming, M.D. has run 6 trials for Pancreatic Cancer. Some of their research focus areas include:
Colorectal Cancer
Dustin Deming, M.D. has run 5 trials for Colorectal Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Wisconsin - Carbone Cancer Center
University Of Wisconsin Carbone Cancer Center - University Hospital
Clinical Trials Dustin Deming, M.D. is currently running
Pembrolizumab + Chemotherapy + Radiation
for Anal Cancer
A single arm phase II study of pembrolizumab, carboplatin, paclitaxel, and radiation for the treatment of early-stage anal cancer. There are 2 treatments phases and then surveillance. The first treatment phase is the chemoradiation phase (Cycle 1-6, weekly cycles) which is followed by the maintenance phase (Cycle 7-14, 6 week cycles).
Recruiting
1 award
Phase 2
10 criteria
ESK981
for Cancer
This protocol will enroll patients with pancreatic adenocarcinoma and adenosquamous carcinoma (Cohort 1), gastrointestinal/pancreatic neuroendocrine neoplasms with Ki-67 \> 20% (Cohort 2) and neuroendocrine prostate carcinoma (Cohort 3)). Each cohort will have its own interim analysis after enrollment of 10 patients. Subjects will be given a one-month (28 day) supply of study drug (ESK981). Subjects will be instructed to take 4 capsules, with or without food, once per day for 5 consecutive calendar days, then take a drug holiday for 2 consecutive days before repeating the 5 days on-2 days off cycle in sets of 4 weeks or 28 calendar days. Subjects will be asked to keep a pill diary noting the date they take their study drug.
Recruiting
1 award
Phase 2
5 criteria
More about Dustin Deming, M.D.
Clinical Trial Related
1 year of experience running clinical trials · Led 17 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Dustin Deming, M.D. has experience with
- Bevacizumab
- Cetuximab
- Panitumumab
- Pembrolizumab
- Oxaliplatin
- Fluorouracil
Breakdown of trials Dustin Deming, M.D. has run
Colorectal Cancer
Cancer
Colon Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dustin Deming, M.D. specialize in?
Dustin Deming, M.D. focuses on Pancreatic Cancer and Colorectal Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are KRAS positive.
Is Dustin Deming, M.D. currently recruiting for clinical trials?
Yes, Dustin Deming, M.D. is currently recruiting for 5 clinical trials in Madison Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Dustin Deming, M.D. has studied deeply?
Yes, Dustin Deming, M.D. has studied treatments such as Bevacizumab, Cetuximab, Panitumumab.
What is the best way to schedule an appointment with Dustin Deming, M.D.?
Apply for one of the trials that Dustin Deming, M.D. is conducting.
What is the office address of Dustin Deming, M.D.?
The office of Dustin Deming, M.D. is located at: University of Wisconsin Carbone Cancer Center, Madison, Wisconsin 53792 United States. This is the address for their practice at the University of Wisconsin Carbone Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.